AMGN

Amgen Inc. Press Releases

$159.6
*  
0.41
0.26%
Get AMGN Alerts
*Delayed - data as of Mar. 5, 2015  -  Find a broker to begin trading AMGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By

Amgen Announces 2015 Second Quarter Dividend
3/4/2015 4:30:00 PM - PR Newswire






























Amgen Submits Applications In The US And Europe For Kyprolis® (carfilzomib) For The Treatment Of Relapsed Multiple Myeloma
1/27/2015 4:02:00 PM - PR Newswire
▲0.34 % Price Change since this news event. The Volume Ratio is 1.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amgen's 2014 Revenues Increased 7 Percent To $20.1 Billion And Adjusted Earnings Per Share (EPS) Increased 14 Percent To $8.70
1/27/2015 4:01:00 PM - PR Newswire
▲0.34 % Price Change since this news event. The Volume Ratio is 1.91.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amgen Announces Webcast of 2014 Fourth Quarter and Full Year Financial Results
1/22/2015 4:01:00 PM - PR Newswire
▲0.06 % Price Change since this news event. The Volume Ratio is 0.78.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amgen Presents New Data Supporting First-Line Use Of Vectibix® (Panitumumab) In Combination With FOLFOX In Patients With Wild-Type RAS Metastatic Colorectal Cancer
1/15/2015 4:01:00 PM - PR Newswire
▲5.06 % Price Change since this news event. The Volume Ratio is 1.09.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day




Amgen and MD Anderson Announce Agreement to Develop BiTE® Therapies for Myelodysplastic Syndrome
1/12/2015 4:01:00 PM - PR Newswire
▲2.16 % Price Change since this news event. The Volume Ratio is 1.48.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amgen To Present At The 33rd Annual J.P. Morgan Healthcare Conference
1/8/2015 4:15:00 PM - PR Newswire
▲1.22 % Price Change since this news event. The Volume Ratio is 1.33.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amgen and Kite Pharma Announce Strategic Cancer Immunotherapy Collaboration to Advance the Application of Novel Chimeric Antigen Receptor (CAR) T Cell Therapies
1/5/2015 9:00:00 AM - PR Newswire
▲1.60 % Price Change since this news event. The Volume Ratio is 2.2.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amgen Joins With LabCentral To Support Life-Sciences And Biotech Startups In Cambridge, Massachusetts
12/22/2014 9:15:00 AM - PR Newswire
▼-5.37 % Price Change since this news event. The Volume Ratio is 0.98.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


Amgen Announces 30 Percent Increase In 2015 First Quarter Dividend
12/17/2014 5:45:00 PM - PR Newswire
▼-2.37 % Price Change since this news event. The Volume Ratio is 1.11.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day